Regulatory Recon: Pfizer Weighs Sale of Consumer Health Business FDA Releases Briefing Documents for Spark Gene Therapy (10 October 2017) Welcome to Regulatory Reconnaissance, your daily regulatory ...
An advisory panel of the U.S. Food and Drug Administration will meet this week to discuss and vote on the composition of the 2026–2027 formula for COVID shots to be used during the next immunization ...
A rare hantavirus outbreak on an Atlantic cruise ship has reignited conspiratorial Covid-era misinformation, with posts sharing files from Pfizer and the World Health Organization (WHO) as supposed ...
May 26 (Reuters) - Advisers to the U.S. Food and Drug Administration will discuss whether COVID-19 vaccines should be updated to target the latest circulating XFG subvariant for the 2026-27 ...
The U.S. Food and Drug Administration (FDA) has approved a label change for Pfizer Inc.'s (NYSE: PFE) Depo-Provera contraceptive injection, adding a warning about the risk of meningioma, a type of ...
There are no hantaviruses in the ingredient list of the Pfizer COVID vaccine, now called Comirnaty. According to Pfizer’s ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results